Rare diseases
Investigational molecules
Locations
Back to France49 clinical trials in Antony, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
FranceStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceStudy on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study
FranceStudy on Lorlatinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer After First-line Treatment Failure
FranceStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
FranceStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
FranceStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
FranceStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceStudy on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
FranceStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
FranceStudy Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Multiple trials are evaluating novel therapeutic approaches for managing these chronic skin conditions.
Several innovative treatments are being tested to improve patient outcomes and quality of life.
Ongoing investigations into treatments for colorectal cancer, multiple myeloma, and bladder cancer. Studies include targeted therapies and novel treatment combinations.
Focus on developing personalized treatment approaches for various cancer types.
Research centered on severe asthma treatment options, particularly focusing on patients with eosinophilic phenotype. Studies are evaluating new biological therapies and treatment comparisons.
Emphasis on developing targeted therapies for specific asthma phenotypes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
